Dudediligence.

Faeth Therapeutics, Inc

FTHNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$7.3MSep ’24−$7.8MDec ’24−$6.9MMar ’25−$4.9MJun ’25−$4.6MSep ’25−$4.7MDec ’25−$170.2MMar ’26−$16.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$37.5M−$50.2M−$37.1M−$32.6M−$22.3M
Net income−$36.8M−$48.6M−$34.1M−$30.2M−$21.1M
Operating cash flow−$30.3M−$39.0M−$32.0M−$24.7M−$20.5M
Free cash flow−$32.3M−$39.3M−$32.2M−$24.8M−$20.5M
Cash$7.2M$17.8M$13.0M$10.0M$8.7M
Shares outstanding30.6M30.8M25.0M1.3M1.3M